A retrospective trial to assess the effect of liraglutide in obese patients with type 2 diabetes mellitus on obstructive sleep apnoea symptoms
Phase of Trial: Phase II
Latest Information Update: 08 Nov 2014
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 08 Nov 2014 New trial record
- 18 Sep 2014 Primary endpoint 'Epworth Sleepiness Scale' has been met according to results presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.
- 18 Sep 2014 Results presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.